SteelPeak Wealth LLC Decreases Stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

SteelPeak Wealth LLC lessened its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 2.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,633 shares of the real estate investment trust’s stock after selling 685 shares during the quarter. SteelPeak Wealth LLC’s holdings in Sabra Health Care REIT were worth $410,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the stock. Tennessee Valley Asset Management Partners acquired a new stake in Sabra Health Care REIT during the fourth quarter worth about $25,000. GAMMA Investing LLC acquired a new stake in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $33,000. Neo Ivy Capital Management acquired a new stake in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $41,000. Principal Securities Inc. acquired a new stake in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $46,000. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $56,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Insider Activity

In other Sabra Health Care REIT news, Director Catherine Cusack purchased 7,000 shares of the business’s stock in a transaction dated Wednesday, May 22nd. The shares were acquired at an average price of $14.43 per share, for a total transaction of $101,010.00. Following the acquisition, the director now owns 46,385 shares of the company’s stock, valued at $669,335.55. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.10% of the stock is owned by insiders.

Sabra Health Care REIT Stock Down 0.3 %

SBRA stock traded down $0.05 during midday trading on Friday, reaching $16.22. The company had a trading volume of 76,602 shares, compared to its average volume of 2,024,628. Sabra Health Care REIT, Inc. has a 1 year low of $11.73 and a 1 year high of $16.94. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $3.80 billion, a P/E ratio of 81.35, a PEG ratio of 2.65 and a beta of 1.24. The company has a 50 day moving average of $15.61 and a two-hundred day moving average of $14.60.

Sabra Health Care REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The company had revenue of $176.14 million during the quarter, compared to analysts’ expectations of $166.54 million. During the same quarter in the previous year, the company earned $0.34 EPS. The firm’s quarterly revenue was up 9.3% compared to the same quarter last year. On average, equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.37 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Monday, August 19th will be issued a dividend of $0.30 per share. The ex-dividend date is Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.40%. Sabra Health Care REIT’s dividend payout ratio is currently 600.00%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Truist Financial increased their price objective on shares of Sabra Health Care REIT from $15.00 to $16.00 and gave the company a “buy” rating in a report on Thursday, June 27th. Scotiabank raised their target price on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 15th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $16.40.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.